Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$CAMP

CAMP4 Therapeutics Corporation Common Stock

XNAS

$4.29+24.40%+$0.8417Prev $3.45LIVE Full chart Live alerts
No recent price bars, the chart lights up when CAMP starts printing.

Why is CAMP up today? It is at $4.29 (+24.40%), and our scanner flagged it 9 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CAMP spikes, and full due diligence on CAMP — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $CAMP alerts the moment volume spikes

Our scanner flagged $CAMP 9 times in the last 30 days. Create a free account to track $CAMP, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$4.29
Change today
+24.40%
Previous close
$3.45
52-week range
$1.32 – $7.75
Valuation & dividend
Market cap
$219M
Ownership & volume
Shares outstanding
51.9M
SEC · as of 2026-05-06 · 90d
Insider ownership
22.1%
DEF 14A · 2026-04-23
Institutional own.
79.94%
Total held
100.0%
Short interest
1.4M
▲ +10% vs prior · as of 2026-07-15
Days to cover
9.1d
Avg daily volume
340K
Classification
Exchange
XNAS
Relative volumevs this time of day
5mthin
100x
15mthin
100x
1hthin
100x
1D
2.2x

Get free CAMP + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $CAMP up today?

Here is the latest on CAMP from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

Likely catalystClinical / FDA update, from the latest SEC filing. Read it →
Why is $CAMP moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile⚡ Ultra-low floatNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201

Dilution watch

Active shelf

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $CAMP runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$CAMP Sentiment

Bullish
Bearish100Bullish
📰 News: 2 bull · 0 bearToday: +24.4%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$CAMP Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 8h ago +14.6% vs EMA
CAMP 200EMA (5m) Trending · 56 bars · L3 · +14.63% above EMA · slope +3.00%
at $4.21
Alert· 8h ago +3.7% vs EMA
CAMP 50EMA (5m) Trending · 56 bars · L3 · +3.69% above EMA · slope +3.21%
at $4.21
Alert· 8h ago +7.1% vs EMA
CAMP 200EMA (1m) Trending · 130 bars · L4 · +7.12% above EMA · slope +1.50%
at $4.21
Alert· 8h ago +7.1% vs EMA
CAMP 200EMA (1m) Trending · 130 bars · L4 · +7.12% above EMA · slope +1.50%
at $4.21
Alert· 8h ago
The Watcher SOLD $CAMP at $4.2700 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"stop_hit","shares":5,"instance":"Rider"}
at $4.27
Alert· 8h ago
The Watcher BOUGHT $CAMP at $4.2500 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · support-reclaim","shares":5,"instance":"Rider"}
at $4.25
Alert· 11h ago +1.8% vs EMA
CAMP 50EMA (1m) Trending · 55 bars · L3 · +1.81% above EMA · slope +4.40%
at $4.11
Alert· 11h ago
The Watcher SOLD $CAMP at $4.1700 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"level_fail","shares":5,"instance":"Rider"}
at $4.17
Alert· 11h ago
The Watcher BOUGHT $CAMP at $4.2500 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · burst-hod","shares":5,"instance":"Rider"}
at $4.25
Alert· 11h ago
The Watcher SOLD $CAMP at $4.1700 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"level_fail","shares":1,"instance":"Rider"}
at $4.17
Alert· 11h ago
The Watcher BOUGHT $CAMP at $4.2500 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · burst-hod","shares":1,"instance":"Rider"}
at $4.25
Alert· 12h ago 2.8× RVOL
CAMP hit 2.826x RVOL at 11:47 AM ET
at $4.21
News· SEC EDGAR· 7d ago
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
Alert· 10d ago 56.6× RVOL
CAMP hit 56.581x RVOL at 3:25 PM ET
at $3.00
Alert· 14d ago 46.3× RVOL
CAMP hit 46.337x RVOL at 3:18 PM ET
at $3.10
News· GlobeNewswire Inc.· 45d ago Neutral
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News· SEC EDGAR· 52d ago
Camp4 Therapeutics Corp filed an 8-K: Executive / Board Change, Shareholder Vote
News· SEC EDGAR· 81d ago
Camp4 Therapeutics Corp filed an 8-K: Regulation FD Disclosure
News· SEC EDGAR· 88d ago
Camp4 Therapeutics Corp filed a Quarterly report (10-Q)
News· GlobeNewswire Inc.· 164d ago Neutral
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News· GlobeNewswire Inc.· 327d ago Bullish
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
News· GlobeNewswire Inc.· 444d ago Bullish
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

CAMP stock FAQ

Why is $CAMP up today?

Here is the latest on CAMP from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

What is the CAMP stock price today?

CAMP last traded at $4.29, up 24.40% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live CAMP alerts?

The CAMP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CAMP 9 times in the last 30 days.

What exchange is CAMP on?

CAMP (CAMP4 Therapeutics Corporation Common Stock) trades on XNAS, with a market cap of about $219M.

Is CAMP good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CAMP for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.